Latest news

nanoPASS Research Highlighted at the Second Harmonisation Workshop 2 December 2024

The Second Harmonisation & Standardisation of Test Methods for Nanomaterials and Advanced Materials Workshop, held virtually on November 18-19, 2024, provided a collaborative forum for advancing testing methodologies and regulatory...

How Tiny Particles Affect Our Lungs: New Research from nanoPASS 13 November 2024

A new study from Helmholtz Munich scientists, Markus Rehberg and Tobias Stoeger, partners in the nanoPASS project, reveals how certain nanoparticles can impact our lungs’ immune response. Published in Advanced...

Unveiling the Bionano Interface: The Tiny Frontier Shaping Big Innovations 5 September 2024

From medicine to cosmetics and even food processing, there’s a microscopic yet critical space where biological and inorganic materials meet—the bionano interface. This junction is key to driving advancements in...

nanoPASS Study Explores Environmental Triggers of Alzheimer’s Disease 24 June 2024

We are thrilled to announce that several partners of the nanoPASS project have co-authored a significant research article titled "Particulate Matter Constituents Trigger the Formation of Extracellular Amyloid β and...

Seminar Highlights: Inhalation of Particles and Dust in the Working Environment 5 June 2024

On May 29th, 2024, Ulla Vogel, a renowned expert in occupational health, delivered a seminar on "Inhalation of Particles and Dust in the Working Environment and Risk of Cardiovascular Disease...

nanoPASS Hosts Webinar on Advanced Methodologies for Regulatory Testing of Nanomaterials 15 May 2024

 In a significant move to advance the safety and regulatory testing of chemicals and materials, the nanoPASS project hosted an impactful webinar titled "AOPs: A Tool to Include NAMs into...

nanoPASS Partner's Commentary in Nature Nanotechnology: A Leap in Nanomaterial Safety 10 April 2024

The nanoPASS consortium celebrates the publication of "Acute, controlled inhalation of thin graphene oxide nanosheets in humans with null cardiorespiratory effects" by  Ulla Vogel of NRCWE in Nature Nanotechnology.  ...

Reflecting on the European Phagocyte Workshop 2024: Insights from nanoPASS partners 8 April 2024

The European Phagocyte Workshop 2024, held in Visegrád, Hungary, from March 20-23, marked a significant milestone in the field of phagocyte research. This year's workshop, following nearly four decades of...

Seminar on Nanoparticle Toxicology Paves the Way for Safer Future 20 March 2024

Ottawa, Canada, March 19, 2024 – In a significant stride toward understanding the impact of nanotechnology on health and environment, Ulla Birgitte Vogel from The National Research Centre for the...

Advancing Nanotoxicology: nanoPASS's Pioneering Role in the OECD-Endorsed Nanomaterial AOP for Pulmonary Fibrosis 14 December 2023

The first nanomaterial-relevant Adverse Outcome Pathway (AOP) has been endorsed by the OECD, which is now referred to as AOPs 33 (formerly known as AOP173). AOPs 33s on ‘Substance interaction...

United for Safety: The Successful Joint Workshop on Nanomaterial Test Harmonisation Spearheaded by nanoPASS and Partners 24 November 2023

The scientific community took a significant leap towards the harmonisation of test methods for nano and advanced materials during a landmark webinar held on 22-23 November 2023. The event was...

First nanoPASS newsletter is out! 29 June 2023

Our first newsletter is out! Find out what we have been up to for the first few months of the project and discover what is coming up. Read the full...

nanoPASS holds consultation with Slovenian nanotoxicity experts 4 May 2023

nanoPASS organised a round-table discussion between partners (JSI, Infinite) and Slovenian experts with interest in nanosafety: researchers of various profiles that deal with nanosafety in different contexts (mechanistic toxicology,...